Concept information
Preferred term
Immunomodulator (substance)
Type
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
Broader concept
Narrower concepts
- Alkylating agent (substance)
- Augmented betamethasone dipropionate
- Belimumab (substance)
- Betamethasone
- Betamethasone acetate
- Betamethasone benzoate
- Betamethasone dipropionate
- Betamethasone esters
- Betamethasone sodium phosphate
- Betamethasone valerate (substance)
- Cetuximab (substance)
- Complement inhibitor
- Dimethyl fumarate (substance)
- Flunisolide
- Imiquimod (substance)
- Immune enhancement agent (substance)
- Immunosuppressant (substance)
- Inosine pranobex (substance)
- Interleukin inhibitor (substance)
- Leflunomide (substance)
- Lenalidomide (substance)
- Lymphocyte function-associated antigen 1 antagonist
- Mediator of immune response and inflammation (substance)
- Mifamurtide
- Ocrelizumab
- Pomalidomide
- Substance with immune checkpoint inhibitor mechanism of action (substance)
- Substance with sphingosine 1-phosphate receptor agonist mechanism of action (substance)
- Teriflunomide (substance)
- Thymosin alpha 1 (substance)
- Treosulfan (substance)
Has disposition
In other languages
-
Persian
URI
http://www.irandoc.acir/onto/irandoc/372558009
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}